GLP-1 has opposing effects on hepatic lipid accumulation and plasma lipid levels, which has recently broadened its clinical use in pharmacological therapy of metabolic syndrome and steatohepatitis 8,9
The key is matching the right medication to the individual patients metabolic profilesomething our expert team addresses through functional assessments
Clin Nutr 2021;40(4):2293-2300
Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa
It is FDA-approved for weight loss (brand name Wegovy) and for diabetes (brand name Ozempic)
3,6,11,12,30 Patient Counseling Points Sitagliptin, saxagliptin, alogliptin, and linagliptin should be taken once daily and may be given without regard to meals